[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

August 2023 | 158 pages | ID: E659A4A27F26EN
The Insight Partners

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe transdermal medical patch market is expected to grow from US$ 2,434.09 million in 2023 to US$ 3,079.58 million by 2028. It is estimated to register a CAGR of 4.8% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Fuels Europe Transdermal Medical Patch Market

Transdermal medical patches are used to administer medications to people suffering from chronic diseases such as heart disease, stroke, diabetes, cancer, obesity, and arthritis.

A cardiac patch provides an excellent platform for cell engraftment improvement. For example, a vascularized cardiac patch developed recently showed promising potential for treating ischemic heart injuries. Nitroglycerin transdermal patches are used to prevent angina (chest pain) episodes in people with coronary artery disease. It works by relaxing the blood vessels and reducing the stress on the heart, thereby lowering the need for oxygen. However, these patches cannot be used to treat angina attacks that have already begun.

Rivastigmine patch is used to treat dementia (memory loss) associated with mild, moderate, or severe Alzheimer's disease or mild-to-moderate dementia associated with Parkinson's disease. Rivastigmine and donepezil, which are cholinesterase inhibitors, exhibit a dose–response relationship, with higher doses of the drugs demonstrating greater efficacy. As a small, lipophilic, and hydrophilic molecule, rivastigmine is chemically well-suited for transdermal delivery. The technology underlying the rivastigmine patch contributes to its discreetly small and thin appearance. Thus, the rivastigmine patch enables quick and easy access to high-dose efficacy.

Therefore, the increasing prevalence of chronic diseases catalyzes the demand for medical patches.

Europe Transdermal Medical Patch Market Overview

The Europe transdermal medical patch market is segmented into the UK, Germany, Spain, Italy, and the Rest of Europe. In 2022, the UK held the largest share of the Europe transdermal medical patch market. The rising number of patients suffering from chronic conditions and viral diseases and increasing activities in research and development are the key factors propelling the market for transdermal medical patches. Also, the growing prevalence of chronic diseases are favoring market expansion.

Europe Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Europe Transdermal Medical Patch Market Segmentation

The Europe transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch and matrix. The matrix segment registered the largest market share in 2023.

Based on application, the Europe transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the Europe transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the Europe transdermal medical patch market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.
1. INTRODUCTION

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
  1.3.1 Europe Transdermal Medical Patch Market – by Type
  1.3.2 Europe Transdermal Medical Patch Market – by Application
  1.3.3 Europe Transdermal Medical Patch Market – by Distribution Channel
  1.3.4 Europe Transdermal Medical Patch Market – by Country

2. TRANSDERMAL MEDICAL PATCH MARKET – KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. EUROPE TRANSDERMAL MEDICAL PATCH MARKET – MARKET LANDSCAPE

4.1 Overview
4.2 PEST Analysis
  4.2.1 Europe PEST Analysis
4.3 Expert’s Opinion

5. EUROPE TRANSDERMAL MEDICAL PATCH MARKET – KEY MARKET DYNAMICS

5.1 Market Drivers
  5.1.1 Increasing Prevalence of Chronic Diseases
  5.1.2 Growing Consumption of Tobacco
5.2 Market Restraints
  5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
5.3 Market Opportunities
  5.3.1 Increasing Strategic Initiatives
5.4 Future Trends
  5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
5.5 Impact analysis

6. TRANSDERMAL MEDICAL PATCH MARKET – EUROPE ANALYSIS

6.1 Europe Transdermal Medical Patch Market Revenue Forecast and Analysis

7. EUROPE TRANSDERMAL MEDICAL PATCH MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE

7.1 Overview
7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
7.3 Single-Layer Drug In-Adhesive
  7.3.1 Overview
  7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Multi-Layer Drug In-Adhesive
  7.4.1 Overview
  7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Reservoir
  7.5.1 Overview
  7.5.2 Reservoir: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Vapor Patch
  7.6.1 Overview
  7.6.2 Vapor Patch: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Matrix
  7.7.1 Overview
  7.7.2 Matrix: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

8. EUROPE TRANSDERMAL MEDICAL PATCH MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION

8.1 Overview
8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
8.3 Neurologic Conditions
  8.3.1 Overview
  8.3.2 Neurologic Conditions: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Pain Management
  8.4.1 Overview
  8.4.2 Pain Management: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Nicotine Cessation
  8.5.1 Overview
  8.5.2 Nicotine Cessation: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiovascular Disorders
  8.6.1 Overview
  8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hormonal Therapy
  8.7.1 Overview
  8.7.2 Hormonal Therapy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
  8.8.1 Overview
  8.8.2 Others: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

9. EUROPE TRANSDERMAL MEDICAL PATCH MARKET – REVENUE AND FORECAST TO 2028 – BY DISTRIBUTION CHANNELS

9.1 Overview
9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
9.3 Hospital Pharmacies
  9.3.1 Overview
  9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
  9.4.1 Overview
  9.4.2 Retail Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Online Pharmacies
  9.5.1 Overview
  9.5.2 Online Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

10. TRANSDERMAL MEDICAL PATCH MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS

10.1 Europe: Transdermal Medical Patch Market
  10.1.1 Overview
  10.1.2 Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
    10.1.2.1 UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.1.1 Overview
      10.1.2.1.2 UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.1.3 UK: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.1.4 UK: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.1.5 UK: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
    10.1.2.2 Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.2.1 Overview
      10.1.2.2.2 Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.2.3 Germany: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.2.4 Germany: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.2.5 Germany: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
    10.1.2.3 France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.3.1 Overview
      10.1.2.3.2 France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.3.3 France: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.3.4 France: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.3.5 France: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
    10.1.2.4 Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.4.1 Overview
      10.1.2.4.2 Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.4.3 Spain: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.4.4 Spain: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.4.5 Spain: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
    10.1.2.5 Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.5.1 Overview
      10.1.2.5.2 Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.5.3 Italy: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.5.4 Italy: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.5.5 Italy: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
    10.1.2.6 Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.6.1 Overview
      10.1.2.6.2 Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
      10.1.2.6.3 Rest of Europe: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
      10.1.2.6.4 Rest of Europe: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
      10.1.2.6.5 Rest of Europe: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. INDUSTRY LANDSCAPE

11.1 Overview
11.2 Growth Strategies
  11.2.1 Overview

12. COMPANY PROFILES

12.1 Hisamitsu Pharmaceutical Co Inc
  12.1.1 Key Facts
  12.1.2 Business Description
  12.1.3 Products and Services
  12.1.4 Financial Overview
  12.1.5 SWOT Analysis
  12.1.6 Key Developments
12.2 Medline Industries LP
  12.2.1 Key Facts
  12.2.2 Business Description
  12.2.3 Products and Services
  12.2.4 Financial Overview
  12.2.5 SWOT Analysis
  12.2.6 Key Developments
12.3 Johnson & Johnson
  12.3.1 Key Facts
  12.3.2 Business Description
  12.3.3 Products and Services
  12.3.4 Financial Overview
  12.3.5 SWOT Analysis
  12.3.6 Key Developments
12.4 Novartis AG
  12.4.1 Key Facts
  12.4.2 Business Description
  12.4.3 Products and Services
  12.4.4 Financial Overview
  12.4.5 SWOT Analysis
  12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
  12.5.1 Key Facts
  12.5.2 Business Description
  12.5.3 Products and Services
  12.5.4 Financial Overview
  12.5.5 SWOT Analysis
  12.5.6 Key Developments
12.6 UCB SA
  12.6.1 Key Facts
  12.6.2 Business Description
  12.6.3 Products and Services
  12.6.4 Financial Overview
  12.6.5 SWOT Analysis
  12.6.6 Key Developments
12.7 Viatris Inc
  12.7.1 Key Facts
  12.7.2 Business Description
  12.7.3 Products and Services
  12.7.4 Financial Overview
  12.7.5 SWOT Analysis
  12.7.6 Key Developments
12.8 Endo Pharmaceuticals Inc
  12.8.1 Key Facts
  12.8.2 Business Description
  12.8.3 Products and Services
  12.8.4 Financial Overview
  12.8.5 SWOT Analysis
  12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
  12.9.1 Key Facts
  12.9.2 Business Description
  12.9.3 Products and Services
  12.9.4 Financial Overview
  12.9.5 SWOT Analysis
  12.9.6 Key Developments

13. APPENDIX

13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES

Table 1. UK Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 7. France Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. France Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. France Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 10. Spain Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Spain Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Spain Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 19. Recent Growth Strategies in Transdermal Medical Patch Market
Table 20. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Transdermal Medical Patch Market Segmentation
Figure 2. Europe Transdermal Medical Patch Market by Region
Figure 3. Europe Transdermal Medical Patch Market Overview
Figure 4. Matrix is The Largest Share of Type Segment in Europe Transdermal Medical Patch Market
Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts’ Opinion
Figure 8. Transdermal Medical Patch Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Transdermal Medical Patch Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Europe Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
Figure 11. Single-Layer Drug In-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Layer Drug In-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Reservoir: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Vapor Patch: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Matrix: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
Figure 17. Neurologic Conditions: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Pain Management: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Nicotine Cessation: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiovascular Disorders: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022 and 2028)
Figure 24. Hospital Pharmacies: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Retail Pharmacies: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Online Pharmacies: Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 29. UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)


More Publications